Benign Prostatic Hyperplasia
BPH is the most common non-cancerous prostate problem and affects the majority of men age 60 to 85. The prostate continues to grow through adulthood. As the gland enlarges, it presses against the urethra, the tube that allows urine to pass out of the body, causing discomfort and difficulty urinating.
The condition’s most effective treatments include removal of the excess prostate tissue blocking the flow of urine. Today’s most advanced minimally invasive surgical options for tissue removal are available at El Camino Health on a “short stay” or outpatient basis.
Our urologic surgeons specialize in:
- GreenLight™ Laser Therapy PVP. PVP stands for photoselective vaporization of the prostate, a procedure where a thin fiber inserted into the urethra delivers laser energy to precisely vaporize prostate tissue blockage.
- PlasmaButton™ for transurethral vaporization of the prostate (TUVP). TUVP is a surgical procedure done on an outpatient or hospital “short stay” basis. It requires inserting a scope, a light source and a vaporizing electrode into the urethra.
AquaBeam® Waterjet Ablation Therapy for endoscopic resection of prostate tissue. The AquaBeam® System combines real-time prostate imaging and surgical robotics to deliver Aquablation, a waterjet ablation therapy that enables targeted, controlled, heat-free and immediate removal of prostate tissue for the treatment of lower urinary tract symptoms caused by BPH.
- UroLift® intra-prostatic suture implant. UroLift is a new minimally invasive FDA-approved procedure that lifts or holds the enlarged prostate tissue out of the way so it no longer blocks the urethra. There is no removal of tissue. It is the only BPH surgical procedure without sexual side effects.
Keep in mind, the symptoms of benign prostatic hyperplasia may resemble other conditions or medical problems, which is why the urologists at El Camino Health perform such thorough examinations. For example, some of the signs of BPH and prostate cancer are the same; a man who has BPH may also have undetected prostate cancer or may develop it in the future.